Pfizer Market Cap 2006-2019 | PFE

Pfizer market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Pfizer market cap as of January 22, 2020 is $222.42B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $222.416B $53.647B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.175B 17.08
Roche Holding AG (RHHBY) Switzerland $291.609B 0.00
Merck (MRK) United States $228.247B 17.68
Novartis AG (NVS) Switzerland $218.202B 18.42
Novo Nordisk (NVO) Denmark $145.206B 25.03
Eli Lilly (LLY) United States $135.916B 25.10
AstraZeneca (AZN) United Kingdom $132.369B 23.91
AbbVie (ABBV) United States $128.968B 10.10
Sanofi (SNY) France $123.704B 15.20
GlaxoSmithKline (GSK) United Kingdom $119.198B 14.44
Bristol-Myers Squibb (BMY) United States $109.863B 15.36
Bayer (BAYRY) Germany $77.402B 11.46
H Lundbeck (HLUYY) Denmark $8.264B 14.36